EUVIMEDEUVIMED entdecken
Crossref

The transaxillary concept for minimally invasive isolated aortic valve replacement: results of 1000 consecutive patients

Manuel Wilbring iD, Sebastian Arzt, Ali Taghizadeh-Waghefi, Asen Petrov, Marco Di Eusanio, Klaus Matschke, Konstantin Alexiou, Utz Kappert iD

European Journal of Cardio-Thoracic Surgery · 2024

DOI: 10.1093/ejcts/ezae427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Manuel Wilbring und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Minimally Invasive Surgical Procedures, Aortic Valve, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES The transaxillary concept for minimally invasive cardiac surgery-aortic valve replacement is a new and versatile approach with nearly no visible scars. Due to its novelty, available data in literature are scarce. This study reports clinical outcomes of 1000 consecutive patients. METHODS Between 2019 and 2023, 4394 patients underwent elective isolated aortic valve procedures, with 2958 (67.5%) transcatheter aortic valve implantation’s and 1436 patients surgical aortic valve replacement’s (32.5%). Within this period, 1st consecutive 1000 transaxillary isolated minimally invasive cardiac surgery-aortic valve replacement were enrolled. Endocarditis, redo’s or combined procedures were excluded. Mean age was 67.9 ± 8.3 years, STS-PROM 1.39 ± 2.89% and EuroScore II 1.65 ± 1.12%. RESULTS Use of the transaxillary access increased from 18.7% (2019) to 97.8% (2023). Mean procedure time was 127 ± 31 min, and average cross-clamp time was 43 ± 14 min. Used prostheses were rapid deployment (81.1%), sutured biologic (14.5%) or sutured mechanical valves (4.1%). Conversion rate was 1.9%. No patient died intraoperatively. Thirty-day major adverse cardiac and cerebrovascular event was 1.9% including 0.9% mortality, 0.8% perioperative stroke and 0.6% myocardial infarction. Multivariate factors for major adverse cardiac and cerebrovascular event are intraoperative conversion [OR 1.08 (1.00–1.16); P = 0.04], intraoperative transfusions [OR 1.21 (1.07–1.38); P < 0.01] and respiratory failure [OR 1.39 (1.30–1.49); P < 0.01]. Corresponding factors for mortality are diabetes on insulin [OR 1.02 (1.00–1.04); P = 0.03], pure aortic regurgitation for primary indication [OR 1.03 (1.01–1.05); P < 0.01], intraoperative conversion [OR 1.11 (1.07–1.16); P < 0.01], renal failure [OR 1.08 (1.05–1.10); P < 0.01] and respiratory failure [OR 1.22 (1.17–1.26); P < 0.01]. CONCLUSIONS Transaxillary minimally invasive cardiac surgery-aortic valve replacement is a safe, effective and cosmetically convincing method for surgical aortic valve replacement, having the potential for >95.0% minimally invasive cardiac surgery rate in selected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Minimally Invasive Surgical ProceduresAortic ValveHeart Valve Prosthesis ImplantationHumansMaleFemaleAgedAxillaMiddle AgedPostoperative ComplicationsRetrospective StudiesOperative TimeHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementTreatment OutcomeAortic Valve Stenosis

Stichwörter der Autor:innen

Aortic valve replacementMinimally invasiveTransaxillaryminimally invasive aortic valve surgerysurgical aortic valve replacement

Autor:innen und Institutionen

  • Center for Minimally Invasive Cardiac Surgery, University Heart Center Dresden, Dresden, Germany.
  • Department of Cardiac Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden Heart Centre, Dresden, Germany.
  • Department of Cardiac Surgery, Ospedali Riuniti, Polytechnic University of Marche, Ancona, Italy.

ORCID-Profile: Manuel Wilbring, Utz Kappert

Zitieren

APA

Wilbring, M., Arzt, S., Taghizadeh-Waghefi, A., Petrov, A., Di Eusanio, M., Matschke, K., Alexiou, K., & Kappert, U. (2024). The transaxillary concept for minimally invasive isolated aortic valve replacement: results of 1000 consecutive patients. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae427

Vancouver

Wilbring M, Arzt S, Taghizadeh-Waghefi A, Petrov A, Di Eusanio M, Matschke K, et al. The transaxillary concept for minimally invasive isolated aortic valve replacement: results of 1000 consecutive patients. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae427

BibTeX
@article{Wilbring2024,
  author = {Wilbring, Manuel and Arzt, Sebastian and Taghizadeh-Waghefi, Ali and Petrov, Asen and Di Eusanio, Marco and Matschke, Klaus and Alexiou, Konstantin and Kappert, Utz},
  title = {The transaxillary concept for minimally invasive isolated aortic valve replacement: results of 1000 consecutive patients},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2024},
  doi = {10.1093/ejcts/ezae427}
}
Kostenlos starten →